Dalacin T Topical Solution

Dalacin T Topical Solution Brand names, Dalacin T Topical Solution Analogs

Dalacin T Topical Solution Brand Names Mixture

No information avaliable

Dalacin T Topical Solution Chemical_Formula

C₁₈H₃₃ClN₂O₅S

Dalacin T Topical Solution RX_link

http://www.rxlist.com/cgi/generic2/clindam.htm

Dalacin T Topical Solution fda sheet

Dalacin_T_Topical_Solution FDA

Dalacin T Topical Solution msds (material safety sheet)

Dalacin T Topical Solution Synthesis Reference

Birkenmeyer, U.S. Pat. 3,475,407(1970)

Dalacin T Topical Solution Molecular Weight

424.984 g/mol

Dalacin T Topical Solution Melting Point

255 ^oC

Dalacin T Topical Solution H₂O Solubility

30.6 mg/L

Dalacin T Topical Solution State

Solid

Dalacin T Topical Solution LogP

1.224

Dalacin T Topical Solution Dosage Forms

Capsules; Intramuscular solution; Intravenousparenteral solution; Topical solution; Topical lotion; Topical gel; Vaginal cream; Vaginal ovules

Dalacin T Topical Solution Indication

For the treatment of serious infections caused by susceptible anaerobic bacteria (anaerobes, streptococci, pneumococci, and staphylococci)

Dalacin T Topical Solution Pharmacology

Clindamycin is an antibiotic, similar to and a derivative of lincomycin. Clindamycin can be used in topical or systemic treatment. It is effective as an anti-anaerobic antibiotic and antiprotozoal.

Dalacin T Topical Solution Absorption

- 90% - oral

Dalacin T Topical Solution side effects and Toxicity

Orally and parenterally administered clindamycin has been associated with severe colitis (pseudomembranous colitis) which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of topical and systemic clindamycin.

Dalacin T Topical Solution Patient Information

Dalacin T Topical Solution Organisms Affected

Enteric bacteria and other eubacteria